Cargando…
Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature
Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and safety of ceftazidime–avibactam as a therapy for...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451286/ https://www.ncbi.nlm.nih.gov/pubmed/37627748 http://dx.doi.org/10.3390/antibiotics12081328 |